Search

everythinglearnresearchcommunity

for

Search:↓

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Long COVID patients have more health issues than non-infected people.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The document concludes that significant investment in agricultural innovation is necessary to achieve global food security and nutrition.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

New therapies are being developed that target integrin pathways to treat various diseases.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

Aesthetic medicine needs clear ethical guidelines to ensure patient well-being and safety.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Insulin resistance linked to obesity may increase COVID-19 severity.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

About 61% of women who had COVID-19 experienced hair loss afterward.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.